Orbia CEO Sameer Bharadwaj has for months been sounding out the possibilities for a sale of Netafim. The Mexican company is ...

Markets are getting jittery after JPMorgan CEO Jamie Dimon pointed to potential cracks in the credit markets following a few regional bank earnings.

Cell and gene therapies (CGTs) are moving rapidly from specialist trials to routine care: more than thirty products are ...

Nvidia (NASDAQ: NVDA) has been one of the most successful stocks in the artificial intelligence (AI) arms race, rising 1,130% ...

Are you wondering what to do with Cognex stock after its recent moves? You are not alone. Investors are taking notice as ...

If you are trying to decide what to do with BP stock right now, you are definitely not alone. Over the last year, BP has been ...

If you’ve been watching Motorola Solutions’ share price and wondering what the next move should be, you’re not alone. The ...

If you’re wondering what to do with Mercedes-Benz Group stock, you’re not alone. While many investors keep their eyes glued to headline-grabbing tech names, Mercedes has quietly delivered strong ...

Palladyne AI Corp.'s technology is compelling, but the company is in an early commercialization stage. Read why PDYN stock is ...

Pakistan can retire some imported coal assets early and still save money. A new report shows the move could be economically ...

We focus on sustainable waste management, recycling wherever possible, and ensuring green cover and designs in redevelopment ...

If you are thinking about what to do with West Pharmaceutical Services stock, you are not alone. The recent moves in the price chart have sparked fresh debate among investors. After rising 3.4% over ...